FDA Clearance Tracker · P030054
ST JUDE MEDICAL EPIC HF SYSTEM
Last checked: Nov 20, 2026Latest source record: Jun 30, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Jun 30, 2004
Approved
Time to decision
194 days
Received Dec 19, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P030054
- Device name
- ST JUDE MEDICAL EPIC HF SYSTEM
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Sylmar, CA
- Received
- Dec 19, 2003
- Decided
- Jun 30, 2004
- Decision
- Approved
- Supplements
- 427 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (CRT-D) (NIK)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ST. JUDE MEDICAL EPIC HF SYSTEM AND THE ST. JUDE MEDICAL ATLAS + HF SYSTEM. THESE SYSTEMS ARE INDICATED FOR THE FOLLOWING: THE ST. JUDE MEDICAL EPIC HF AND ATLAS + HF SYSTEMS ARE INTENDED TO PROVIDE VENTRICULAR ANTITACHYCARDIA PACING AND VENTRICULAR DEFIBRILLATION FOR AUTOMATED TREATMENT OF LIFE-THREATENING VENTRICULAR ARRHYTHMIAS. THE EPIC HF AND ATLAS + HF SYSTEMS ARE ALSO INTENDED TO PROVIDE A REDUCTION OF THE SYMPTOMS OF MODERATE TO SEVERE HEART FAILURE (NYHA FUNCTIONAL CLASS III OR IV) IN THOSE PATIENTS WHO REMAIN SYMPTOMATIC DESPITE STABLE, OPTIMAL MEDICAL THERAPY (AS DEFINED IN THE CLINICAL TRIALS SECTION), AND HAVE A LEFT VENTRICULAR EJECTION FRACTION LESS THAN OR EQUAL TO 35% AND A PROLONGED QRS DURATION.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NIK. The earliest in FDA's data is P010012, decided May 2, 2002.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.